| Trial ID: | L0785 |
| Source ID: | ChiCTR1800018629
|
| Associated Drug: |
Vitamin E
|
| Title: |
Pathogenesis and therapeutic targeting of non-alcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
non-alcoholic steatohepatitis
|
| Interventions: |
Strict diet control group:There is no drug treatment, and patients are required to strictly control their diet, formulate a professional diet table and exercise strictly;Diammonium glycyrrhizate enteric capsule single drug group:Diammonium glycyrrhizate e
|
| Outcome Measures: |
glutamic oxalacetic transaminase ;glutamic-pyruvic transaminase ;albumin;triglyceride; low density lipoprotein ;Blood glucose;Fat attenuation using Fibroscan;Magnetic Resonance Imaging Proton Density Fat Fraction;IDEAL IQ;T1mapping;T2*mapping;sADC IVIM;nan
|
| Sponsor/Collaborators: |
First Affiliated Hospital, Jilin University
|
| Gender: |
All
|
| Age: |
1865
|
| Phases: |
New Treatment Measure Clinical Study
|
| Enrollment: |
Strict diet control group:50;Diammonium glycyrrhizate enteric capsule single drug group:50;Vitamin E monotherapy group:50;Application group of diammonium glycyrrhizate enteric capsule and vitamin E:50;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Randomized parallel controlled trial
|
| Start Date: |
30/09/2018
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
1 October 2018
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=31420
|
